CompaniesIlkos Therapeutic

Ilkos Therapeutic

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

121

By Phase

PHASE2: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
Today
NCT03077165
Hover over trial bars to see details

Recent Trials

NCT03077165Lead Sponsor
Dose-response Relationship Study of S42909 on Leg Ulcer Healing
PHASE2Completed
121 participants
Started: Sep 12, 2017 · Completed: Jan 22, 2020
Related Companies
Odan Laboratories
acquired